1 The underlying neoplastic procedures of colorectal carcinogenesis lend themselves to screening.

Thomas F more . Imperiale, M.D., David F. Ransohoff, M.D., Steven H. Itzkowitz, M.D., Theodore R. Levin, M.D., Philip Lavin, Ph.D., Graham P. Lidgard, Ph.D., David A. Ahlquist, M.D., and Barry M. Berger, M.D.: Multitarget Stool DNA Testing for Colorectal-Cancer Screening Colorectal cancer is a significant cause of death and disease among women and men in the United States.1 The underlying neoplastic procedures of colorectal carcinogenesis lend themselves to screening.2 Evidence supports and recommendations endorse several testing and strategies,3-5 and screening for colorectal malignancy has been found to be cost-effective.5-7 Despite the supporting evidence, suggestions, and availability of several screening tests, a substantial proportion of the U.S.

Michael P. Gemstone, M.D., Richard S. Legro, M.D., Christos Coutifaris, M.D., Ph.D, Ruben Alvero, M.D., Randal D. Robinson, M.D., Peter Casson, M.D., Gregory M. Christman, M.D., Joel Ager, Ph.D., Hao Huang, M.D., M.P.H., Karl R. Hansen, M.D., Ph.D., Valerie Baker, M.D., Rebecca Usadi, M.D., Aimee Seungdamrong, M.D., G. Wright Bates, M.D., R. Mitchell Rosen, M.D., Daniel Haisenleder, Ph.D., Stephen A. Krawetz, Ph.D., Kurt Barnhart, M.D., J.C. Trussell, M.D., Dana Ohl, M.D., Yufeng Jin, M.S., Nanette Santoro, M.D., Esther Eisenberg, M.D., M.P.H., and Heping Zhang, Ph.D. For the NICHD Reproductive Medication Network: Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility.